Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 5;9(11):1626.
doi: 10.3390/biomedicines9111626.

Lupus Vasculitis: An Overview

Affiliations
Review

Lupus Vasculitis: An Overview

Patrizia Leone et al. Biomedicines. .

Abstract

Lupus vasculitis (LV) is one of the secondary vasculitides occurring in the setting of systemic lupus erythematosus (SLE) in approximately 50% of patients. It is most commonly associated with small vessels, but medium-sized vessels can also be affected, whereas large vessel involvement is very rare. LV may involve different organ systems and present in a wide variety of clinical manifestations according to the size and site of the vessels involved. LV usually portends a poor prognosis, and a prompt diagnosis is fundamental for a good outcome. The spectrum of involvement ranges from a relatively mild disease affecting small vessels or a single organ to a multiorgan system disease with life-threatening manifestations, such as mesenteric vasculitis, pulmonary hemorrhage, or mononeuritis multiplex. Treatment depends upon the organs involved and the severity of the vasculitis process. In this review, we provide an overview of the different forms of LV, describing their clinical impact and focusing on the available treatment strategies.

Keywords: lupus vasculitis; small vessel vasculitis; systemic lupus erythematosus; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pathogenesis of lupus vasculitis. Abbreviations: SLE = systemic lupus erythematosus, Ag = antigen, Ab = antibody, IC = immune complex, ICAM-1 = intercellular adhesion molecule 1, VCAM-1 = vascular cell adhesion molecule 1, IL = interleukin, and PMN = polymorphonuclear cell.
Figure 2
Figure 2
Necrotic purpuric plaques with ulcerations.
Figure 3
Figure 3
Deep leg ulcer.
Figure 4
Figure 4
Skin biopsies showing leukocytoclastic vasculitis in SLE patients. The inflammatory lesions are evident in the perivascular derma, associated with nuclear dust and subepithelial myxoid degeneration. (A,B) original magnification: 40×, scale bar, 50 µm and (C,D) original magnification: 100×, scale bar, 25 µm.
Figure 5
Figure 5
Diffuse alveolar hemorrhage. A chest radiography shows bilateral widespread infiltrates in both medium lower fields. A chest computed tomography shows left pulmonary embolism and massive diffuse infiltration of both lung fields. R means right.

Similar articles

Cited by

References

    1. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008;358:929–939. doi: 10.1056/NEJMra071297. - DOI - PubMed
    1. Doyle M.K. Vasculitis associated with connective tissue disorders. Curr. Rheumatol. Rep. 2006;8:312–316. doi: 10.1007/s11926-006-0015-5. - DOI - PubMed
    1. Leone P., Cicco S., Vacca A., Dammacco F., Racanelli V. Vasculitis in connective tissue diseases. In: Dammcco F., Ribatti D., Vacca A., editors. Systemic Vasculitides: Current Status and Perspectives. Springer International Publishing; Cham, Switzerland: 2016. pp. 345–359.
    1. Drenkard C., Villa A.R., Reyes E., Abello M., Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus. 1997;6:235–242. doi: 10.1177/096120339700600304. - DOI - PubMed
    1. Ramos-Casals M., Nardi N., Lagrutta M., Brito-Zeron P., Bove A., Delgado G., Cervera R., Ingelmo M., Font J. Vasculitis in systemic lupus erythematosus: Prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 2006;85:95–104. doi: 10.1097/01.md.0000216817.35937.70. - DOI - PubMed

LinkOut - more resources